Bayer

This study will follow 500 men in Germany with metastatic hormone-sensitive prostate cancer (mHSPC) who are taking darolutamide plus standard hormone therapy. The main goal is to see how many men have very low PSA levels after 12 months. Researchers will also track survival and h…

This study looks at the safety and real-world use of Octocog alfa, a lab-made clotting factor, for treating bleeding episodes in adults with severe hemophilia A in India. About 33 people who have used factor VIII before will receive the drug on-demand when they have a bleed. Rese…

This study tests a single injection of AB-1005 gene therapy directly into the brain for Japanese adults with moderate Parkinson's disease. The goal is to see if it is safe and can improve motor function and reduce daily symptoms. Eight participants will be followed for 18 months …

This study looks at how well elinzanetant, a hormone-free medicine, works for hot flashes, night sweats, and sleep problems in menopausal women. About 1,500 women in the U.S. will use a phone app to report their symptoms and quality of life over 12 weeks to 2 years. The goal is t…

This study collects information from medical records of up to 850 children under 2 years old who have blood clots (VTE) and are being treated with rivaroxaban (Xarelto) or other standard blood thinners. Researchers will track how these medicines are prescribed, how long they are …

This study follows 50 pregnant women with Chagas disease who take or have taken nifurtimox, a drug used for over 50 years. Researchers will track birth defects, pregnancy outcomes, and infant health up to 12 months old. The goal is to gather safety data, not to test a new treatme…